British Skull Base Society Consensus on Vestibular Schwannoma Surveillance
Mantegh Sethi,Daniele Borsetto,James Tysome,Juliette Buttimore,Nicola Gamazo,Richard Mannion,Matthew Guilfoyle,Manohar Bance,Rupert Obholzer,Tilak Das,Dan Scoffings,Thais Minett,Jonathan Jones,Yogish Joshi,Francis Scott,Tomasz Matys,Simon Freeman,Simon Lloyd,Scott Rutherford,Gillian Potter,Rekha Siripurapu,Sarah Abdulla,Roger Laitt,Ziyad Saloojee,David Summers,Shakeel R. Saeed,Fabrizio Bandino,Samuel MacKeith,Sanjeeva Jeyaretna,Carl Philpott,Jagrit Shah,Iain Robertson,Sebastian Thomas,Nameet Hattangadi,Alessandro Paluzzi,Andrew Kay,Bushra Awan,Rhian Rhys,Senthil Muthu,Philip J Clamp,Ravi Nannapaneni,Caroline Hayhurst,Nihal Gurusinghe,Andrew Alalade,Catherine Gilkes,Nazia Munir,Ahmed Yousseff,Parag Patel,Susanne Hampton,Charlotte Hammerbeck-Ward,Nick Saunders,Richard Irving,Peter Monksfield,Nicholas Thomas,Neil Kitchen,Sinan Barazi,Eleni Maratos,Steve Connor,Colin Leonard,Nicholas Dawe,Hassan Mohamed,Patrick Axon,Neil Donnelly
DOI: https://doi.org/10.1055/s-0044-1792035
2024-11-07
Journal of Neurological Surgery Part B Skull Base
Abstract:Objective Surveillance plays a crucial role in managing patients with vestibular schwannomas (VSs). Consensus is lacking on the optimal duration, frequency, and modality of imaging. Standardizing this approach would ensure safe and effective care, reduce patient distress, and promote consistency in management decisions among clinicians. Methods In July 2022, a multi-disciplinary Delphi consensus was conducted at the British Skull Base Society Meeting. Expert United Kingdom-based skull-base surgeons and neuroradiologists were presented semi-systematic literature reviews summarizing current evidence on VS management. Anonymized opinions were collated and discussed to reach a majority vote, which was deemed the final consensus opinion. Results Recommendations for VS managed by surveillance are: (1) surveillance frequency should decrease over time; (2) surveillance may be discontinued when the remaining lifetime risk of VS growth is <0.5% (∼8.5 years); (3) factors such as age, VS size, VS location, and cystic components should be considered. Surveillance after surgery or radiotherapy has limited evidence but recommendations are: (4) surveillance should be adjusted based on residual tumor size or nodular enhancement. Imaging modality and sequences are recommended to be (5) high-resolution magnetic resonance imaging with T1, T2, FIESTA/CISS multiplanar sequences, contrast is not required in untreated cases, and linear reporting of measurements is pragmatically sufficient. Conclusion This consensus and literature review provides an evidence and expert opinion–based guide to help clinicians with the surveillance of patients with VS. Further research should focus on better understanding the dynamic nature of growth risks and the growth characteristics of postintervention VS to enable personalized growth risk stratification. * The first two authors contributed equally to the paper. Received: 26 February 2024 Accepted: 06 October 2024 Article published online: 05 November 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
surgery,clinical neurology